Wellmark Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-04-2024
- Paid Up Capital ₹ 0.10 M
as on 22-04-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -99.86%
(FY 2020)
- Profit -758.13%
(FY 2020)
- Ebitda -339.13%
(FY 2020)
- Net Worth -49.38%
(FY 2020)
- Total Assets -82.18%
(FY 2020)
About Wellmark Lifesciences
- CIN/LLPIN
U51109KA2016PTC085640
- Company No.
085640
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2016
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wellmark Lifesciences Private Limited offer?
Wellmark Lifesciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Aceclofenac, Muscle Relaxant.
Who are the key members and board of directors at Wellmark Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Kumar  | Managing Director | 29-Jan-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geetha | Additional Director | 11-Apr-2022 | Current |
Financial Performance of Wellmark Lifesciences.
Wellmark Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.86% decrease. The company also saw a substantial fall in profitability, with a 758.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellmark Lifesciences?
In 2020, Wellmark Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellmark Lifesciences?
Unlock and access historical data on people associated with Wellmark Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellmark Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellmark Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
